Fennec Pharmaceuticals, Inc. (FENC)
9.81
-0.12
(-1.21%)
USD |
NASDAQ |
May 26, 13:31
Fennec Pharmaceuticals Profit Margin (Quarterly) : 1.33% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -177.9% |
| Gossamer Bio, Inc. | -275.2% |
| REGENXBIO, Inc. | -1.41K% |
| Zymeworks, Inc. | -1.83K% |
| Apellis Pharmaceuticals, Inc. | 6.95% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.94% |
| Return on Assets | -15.43% |
| Return on Invested Capital | -39.84% |
| Gross Profit Margin (Quarterly) | 96.23% |
| Operating Margin (Quarterly) | -0.79% |
| Return on Net Operating Assets | -31.15% |